Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Discovery Grants Program - Individual

University of Calgary

$39,000.00

Chronic infection and inflammation at mucosal surfaces

FY 2011-12

Summary
A thin layer of mucous separates the luminal surface of the respiratory, digestive, and urogenital tracts from the outside world, making these surfaces of the body the most prone to infection and inflammation. My laboratory, using the rat prostate as a model system, has studied the role of bacterial virulence factors, which are weapons used by bacteria to attack the host, in helping bacteria to establishing chronic infections by forming biofilms at these surfaces. Biofilms are bacteria growing as interactive colonies within a slime layer attached to tissues or implanted medical devices that are less susceptible to the host immune system and to antibiotic treatment, thus allowing them to persist. We have developed new technologies for assaying antimicrobial susceptibility of biofilms, which has resulted in a multifactorial model to explain the resistance of biofilms. In future, we will continue to study infection and inflammation at mucosal surfaces and mechanisms of antimicrobial resistance of biofilms. First we will expand the use of the prostate as a more general model of mucosal inflammation to study Pseudomonas biofilm infections as seen in cystic fibrosis (CF). Since the normal lung clears Pseudomonas infections readily we will use the prostate, a mucosal surface more susceptible to biofilm formation, as a model of these infections of the CF lung. We will also move the model into the mouse, which has become the prime model to study the immune response. This will allow us to better ascertain the contribution of the host's immune system to the inflammatory disease process initiated by biofilm formation. Secondly, we will continue our study of the adaptations of bacteria in biofilms that result in their reduced antimicrobial susceptibility by characterizing the proteins made by biofilms under challenge in order to define the mechanisms initiated to stave off elimination by antibiotics. Further we will look at the role of enzymes involved in limiting damage from reactive oxygen species in contributing to the stability of biofilms under antimicrobial stress. We anticipate that these studies will allow us to better understand and in the long term control chronic mucosal infections.
Program
Discovery Grants Program - Individual
Location
Alberta, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
2805-2008
Name nom
Ceri, Howard
Department département
Biological Sciences
Organization id
11
Institution établissement
University of Calgary
Province en
Alberta
Province fr
Alberta
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2011
Competition year année de concours
2008
Award amount
39000
Program id
RGPIN
Program nane en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
32
Committee name en
Cell Biology
Committee name fr
Biologie cellulaire
Area of application code
1201
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Life sciences (including biotechnology)
Area of application fr
Sciences de la vie (y compris biotechnologie)
Research subject code
5200
Research subject group en
Microbiology
Research subject group fr
Microbiologie
Research subject en
Microbiology
Research subject fr
Microbiologie
Partie
4
Nb partie
5
Application title
Chronic infection and inflammation at mucosal surfaces
Keyword
NSERC
Application summary
A thin layer of mucous separates the luminal surface of the respiratory, digestive, and urogenital tracts from the outside world, making these surfaces of the body the most prone to infection and inflammation. My laboratory, using the rat prostate as a model system, has studied the role of bacterial virulence factors, which are weapons used by bacteria to attack the host, in helping bacteria to establishing chronic infections by forming biofilms at these surfaces. Biofilms are bacteria growing as interactive colonies within a slime layer attached to tissues or implanted medical devices that are less susceptible to the host immune system and to antibiotic treatment, thus allowing them to persist. We have developed new technologies for assaying antimicrobial susceptibility of biofilms, which has resulted in a multifactorial model to explain the resistance of biofilms. In future, we will continue to study infection and inflammation at mucosal surfaces and mechanisms of antimicrobial resistance of biofilms. First we will expand the use of the prostate as a more general model of mucosal inflammation to study Pseudomonas biofilm infections as seen in cystic fibrosis (CF). Since the normal lung clears Pseudomonas infections readily we will use the prostate, a mucosal surface more susceptible to biofilm formation, as a model of these infections of the CF lung. We will also move the model into the mouse, which has become the prime model to study the immune response. This will allow us to better ascertain the contribution of the host's immune system to the inflammatory disease process initiated by biofilm formation. Secondly, we will continue our study of the adaptations of bacteria in biofilms that result in their reduced antimicrobial susceptibility by characterizing the proteins made by biofilms under challenge in order to define the mechanisms initiated to stave off elimination by antibiotics. Further we will look at the role of enzymes involved in limiting damage from reactive oxygen species in contributing to the stability of biofilms under antimicrobial stress. We anticipate that these studies will allow us to better understand and in the long term control chronic mucosal infections.